Resolution Pharmacology – new therapeutic approaches for the treatment of inflammatory diseases

Patrícia Silva,
Researcher in Public Health, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil

Professor Mauro Perretti,
Dean for Research and Research Impact SMD, Queen Mary University of London, London, United Kingdom

Development of FPR2 small molecules to treat heart failure: from preclinical to phase I trial
Dr Ricardo Garcia
Sr. Principal Scientist, Bristol-Myers Squibb Co., Princeton, NJ, The United States of America

Advances in antifibrotic therapies for chronic lung diseases
Dr Patrícia Silva
Senior Researcher in Public Health, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil

Oral communication speaker - to be confirmed in 2023.

Plasminogen/plasmin: novel players in the resolution of inflammation
Dr Lirlândia Souza
Federal University of Minas Gerais, Belo Horizonte, Brazil

AP1189: a biased agonist for melanocortin receptors in Phase IIa
Professor Thomas Jonassen
Syn Act Pharma, Holt, Denmark